Scroll back to top

Hepatitis C Virus

Close

Hepatitis C Virus

In 2016, there were an estimated 2.4 million people living with hepatitis C in the United States. Many people may not have symptoms or don’t know they are infected, their illness is often not diagnosed. Approximately 75%-80% of people who become infected with hepatitis C virus will develop a chronic infection.1

About 6 in 100 infants who are born to mothers with hepatitis C become infected with the hepatitis C virus. The risk becomes greater if the mother has both HIV and hepatitis C.1

The CDC guidelines2 recommend screening for:

  • Testing women born between 1945 and 1965 who are not aware of their infection status
  • All persons with human immunodeficiency virus (HIV) infection
  • History of injecting illegal drugs
  • Recipients of clotting factor concentrates, before 1987
  • Patients who were ever on chronic (long-term) hemodialysis
  • People with persistently abnormal alanine aminotransferase levels
  • Recipients of blood from donors who later tested positive for hepatitis C virus infection
  • Recipients of blood or blood-component transfusion or organ transplant before July 1992
  • Occupational percutaneous or mucosal exposure to hepatitis C virus-positive blood

LabCorp, and its specialty laboratory Monogram Biosciences, offer a comprehensive menu for screening and treating patients with Hepatitis C (HCV). LabCorp was the first to develop valuable viral resistance testing for patients undergoing HCV treatment.

For more information, please download the following brochures:

Reference

  1. Centers for Disease Control and Prevention. Viral Hepatitis: Hepatitis C questions and answers for the public. https://www.cdc.gov/hepatitis/hcv/cfaq.htm
  2. Centers for Disease Control and Prevention. Viral Hepatitis: Testing recommendations for Hepatitis C virus infection. https://www.cdc.gov/hepatitis/hcv/guidelinesc.htm